BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Clinical Outcome
7 results:

  • 1. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
    Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
    J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
    Zhang X; Yu K; Ma L; Qian Z; Tian X; Miao Y; Niu Y; Xu X; Guo S; Yang Y; Wang Z; Xue X; Gu C; Fang W; Sun J; Yu Y; Wang J
    Theranostics; 2021; 11(12):5650-5674. PubMed ID: 33897873
    [No Abstract]    [Full Text] [Related]  

  • 3. Advantages and disadvantages of corticosteroid use for acute exacerbation of interstitial pneumonia after pulmonary resection.
    Fukui M; Takamochi K; Suzuki K; Ando K; Matsunaga T; Hattori A; Oh S; Suzuki K
    Gen Thorac Cardiovasc Surg; 2021 Mar; 69(3):472-477. PubMed ID: 32939629
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation.
    Xu P; Jiang L; Yang Y; Wu M; Liu B; Shi Y; Shen Q; Jiang X; He Y; Cheng D; Xiong Q; Yang Z; Duan L; Lin J; Zhao S; Shi P; Yang C; Chen Y
    Theranostics; 2020; 10(8):3767-3778. PubMed ID: 32206121
    [No Abstract]    [Full Text] [Related]  

  • 5. MicroRNA-7 as a potential therapeutic target for aberrant NF-κB-driven distant metastasis of gastric cancer.
    Ye T; Yang M; Huang D; Wang X; Xue B; Tian N; Xu X; Bao L; Hu H; Lv T; Huang Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):55. PubMed ID: 30728051
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
    Han JY; Lee YS; Shin ES; Hwang JA; Nam S; Hong SH; Ghang HY; Kim JY; Yoon SJ; Lee JS
    Pharmacogenomics J; 2014 Feb; 14(1):20-7. PubMed ID: 23478653
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Randomized phase II study of maintenance irinotecan therapy versus observation following induction chemotherapy with irinotecan and cisplatin in extensive disease small cell lung cancer.
    Han JY; Kim HT; Lim KY; Yoon SJ; Lee DH; Lee JS
    J Thorac Oncol; 2008 Sep; 3(9):1039-45. PubMed ID: 18758308
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.